MarketLens
Sign Up

What Caused uniQure's Dramatic Stock Plunge

7 months ago
SHARE THIS ON:

What Caused uniQure's Dramatic Stock Plunge

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

Uniqure Plummets 40% On Another Shocking Twist For Its Huntington's Drug

Uniqure shares fell 40% Tuesday after a four-year update on its experimental Huntington's disease gene therapy disappointed investors. The decline reflects renewed uncertainty over the program's durab...
Stock News•1 months ago

RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy

REGENXBIO (RGNX) fell 25% after the FDA placed a clinical hold on RGX-121 for MPS II, following asymptomatic spine MRI findings in five participants.
Stock News•2 months ago

Capricor Therapeutics Stock Plunges After FDA Releases Briefing Documents

Capricor Therapeutics shares fell over 60% Monday after the FDA released briefing documents ahead of the July 29 advisory committee meeting.

Breaking News

View All →

Top Headlines

View More →
Stock News•31 minutes ago

Tesla's stock falls as Elon Musk leaves investors wanting more

Stock News•53 minutes ago

Meta's stock rises as investors glimpse an opportunity that could dwarf the ad business

Stock News•58 minutes ago

Q3 Earnings Beats for Meta, Tesla, IBM and T.I.

Stock News•59 minutes ago

Meta Q3: From Facebook To Muse, Strong Growth Makes This A Strong Buy

Stock News•1 hour ago

2 Healthcare Stocks to Buy After Crushing Q3 Earnings Expectations: ELV & ISRG